Peripheral neuropathies in Sjögren's syndrome: A critical update on clinical features and pathogenetic mechanisms

Journal of Autoimmunity

Volumn 39, Issue 1-2, 2012, Pages 27-33

  Pavlakis, P P ^a   Alexopoulos, H ^a   Kosmidis, M L ^a   Mamali, I ^a   Moutsopoulos, H M ^a   Tzioufas, A G ^a   Dalakas, M C ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Autoantibodies; Ganglionopathy; Polyneuropathy; Sj gren's syndrome; Small fiber neuropathy; Vasculitis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; COMPLEMENT COMPONENT C4;

ANEMIA; ARTHRALGIA; ARTHRITIS; ARTICLE; AUTONOMIC NEUROPATHY; AXONAL SENSORIMOTOR POLYNEUROPATHY; B LYMPHOCYTE; CANCER RISK; CLINICAL FEATURE; CRANIAL MONONEUROPATHY; CRYOGLOBULINEMIA; DEMYELINATING POLYRADICULONEUROPATHY; DISEASE ASSOCIATION; ELECTROPHYSIOLOGY; FATIGUE; FEVER; GLOMERULONEPHRITIS; HUMAN; HYPERGAMMAGLOBULINEMIA; INCIDENCE; INTRAEPIDERMAL NERVE FIBER; LEUKOPENIA; LYMPHOMA; MONONEUROPATHY; MONONEUROPATHY MULTIPLEX; NERVE FIBER; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PARESTHESIA; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PRURITUS; PURPURA; RAYNAUD PHENOMENON; SALIVARY GLAND DISEASE; SALIVARY GLAND HYPERTROPHY; SENSORIMOTOR NEUROPATHY; SENSORY ATAXIC NEUROPATHY; SENSORY AXONAL POLYNEUROPATHY; SJOEGREN SYNDROME; SMALL FIBER NEUROPATHY; SYSTEMIC DISEASE; T LYMPHOCYTE; VASCULITIS; XEROPHTHALMIA; XEROSTOMIA;

AUTOIMMUNITY; B-LYMPHOCYTES; CRYOGLOBULINEMIA; DEMYELINATING DISEASES; EXOCRINE GLANDS; HUMANS; PERIPHERAL NERVOUS SYSTEM DISEASES; SENSATION DISORDERS; SJOGREN'S SYNDROME; T-LYMPHOCYTES; VASCULITIS;

EID: 84862494181     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.01.003     Document Type: Article

References (107)

1. Mavragani C.P., Moutsopoulos N.M., Moutsopoulos H.M. The management of Sjogren's syndrome. Nat Clin Pract Rheumatol 2006, 2:252-261.
2. Tzioufas A.G., Voulgarelis M. Update on Sjogren's syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract Res Clin Rheumatol 2007, 21:989-1010.
3. Kassan S.S., Moutsopoulos H.M. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med 2004, 164:1275-1284.
4. Fox R.I. Sjogren's syndrome. Lancet 2005, 366:321-331.
5. Andonopoulos A.P., Lagos G., Drosos A.A., Moutsopoulos H.M. Neurologic involvement in primary Sjogren's syndrome: a preliminary report. J Autoimmun 1989, 2:485-488.
6. Andonopoulos A.P., Lagos G., Drosos A.A., Moutsopoulos H.M. The spectrum of neurological involvement in Sjogren's syndrome. Br J Rheumatol 1990, 29:21-23.
7. Barendregt P.J., van den Bent M.J., van Raaij-van den Aarssen V.J., van den Meiracker A.H., Vecht C.J., van der Heijde G.L., et al. Involvement of the peripheral nervous system in primary Sjogren's syndrome. Ann Rheum Dis 2001, 60:876-881.
8. Binder A., Snaith M.L., Isenberg D. Sjogren's syndrome: a study of its neurological complications. Br J Rheumatol 1988, 27:275-280.
9. Gemignani F., Marbini A., Pavesi G., Di Vittorio S., Manganelli P., Cenacchi G., et al. Peripheral neuropathy associated with primary Sjogren's syndrome. J Neurol Neurosurg Psychiatry 1994, 57:983-986.
10. Govoni M., Bajocchi G., Rizzo N., Tola M.R., Caniatti L., Tugnoli V., et al. Neurological involvement in primary Sjogren's syndrome: clinical and instrumental evaluation in a cohort of Italian patients. Clin Rheumatol 1999, 18:299-303.
11. Harboe E., Tjensvoll A.B., Maroni S., Goransson L.G., Greve O.J., Beyer M.K., et al. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjogren syndrome: a comparative population-based study. Ann Rheum Dis 2009, 68:1541-1546.
12. Lafitte C., Amoura Z., Cacoub P., Pradat-Diehl P., Picq C., Salachas F., et al. Neurological complications of primary Sjogren's syndrome. J Neurol 2001, 248:577-584.
13. Lopate G., Pestronk A., Al-Lozi M., Lynch T., Florence J., Miller T., et al. Peripheral neuropathy in an outpatient cohort of patients with Sjogren's syndrome. Muscle Nerve 2006, 33:672-676.
14. Mauch E., Volk C., Kratzsch G., Krapf H., Kornhuber H.H., Laufen H., et al. Neurological and neuropsychiatric dysfunction in primary Sjogren's syndrome. Acta Neurol Scand 1994, 89:31-35.
15. Ramos-Casals M., Solans R., Rosas J., Camps M.T., Gil A., Del Pino-Montes J., et al. Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 2008, 87:210-219.
16. Skopouli F.N., Dafni U., Ioannidis J.P., Moutsopoulos H.M. Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome. Semin Arthritis Rheum 2000, 29:296-304.
17. Vrethem M., Lindvall B., Holmgren H., Henriksson K.G., Lindstrom F., Ernerudh J. Neuropathy and myopathy in primary Sjogren's syndrome: neurophysiological, immunological and muscle biopsy results. Acta Neurol Scand 1990, 82:126-131.
18. Pavlakis P.P., Alexopoulos H., Kosmidis M.L., Stamboulis E., Routsias J.G., Tzartos S.J., et al. Peripheral neuropathies in Sjogren syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry 2010.
19. Goransson L.G., Herigstad A., Tjensvoll A.B., Harboe E., Mellgren S.I., Omdal R. Peripheral neuropathy in primary Sjogren syndrome: a population-based study. Arch Neurol 2006, 63:1612-1615.
20. Grant I.A., Hunder G.G., Homburger H.A., Dyck P.J. Peripheral neuropathy associated with sicca complex. Neurology 1997, 48:855-862.
21. Mori K., Iijima M., Koike H., Hattori N., Tanaka F., Watanabe H., et al. The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain 2005, 128:2518-2534.
22. Delalande S., de Seze J., Fauchais A.L., Hachulla E., Stojkovic T., Ferriby D., et al. Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine (Baltimore) 2004, 83:280-291.
23. Pavlakis P.P., Alexopoulos H., Kosmidis M.L., Stamboulis E., Routsias J.G., Tzartos S.J., et al. Peripheral neuropathies in Sjögren syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry 2011, 82:798-802.
24. Dworkin R.H., O'Connor A.B., Backonja M., Farrar J.T., Finnerup N.B., Jensen T.S., et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007, 132:237-251.
25. Sghirlanzoni A., Pareyson D., Lauria G. Sensory neuron diseases. Lancet Neurol 2005, 4:349-361.
26. Dalakas M.C. Chronic idiopathic ataxic neuropathy. Ann Neurol 1986, 19:545-554.
27. Griffin J.W., Cornblath D.R., Alexander E., Campbell J., Low P.A., Bird S., et al. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogren's syndrome. Ann Neurol 1990, 27:304-315.
28. Souayah N., Chong P.S., Cros D. Acute sensory neuronopathy as the presenting symptom of Sjogren's syndrome. J Clin Neurosci 2006, 13:862-865.
29. Mori K., Koike H., Misu K., Hattori N., Ichimura M., Sobue G. Spinal cord magnetic resonance imaging demonstrates sensory neuronal involvement and clinical severity in neuronopathy associated with Sjogren's syndrome. J Neurol Neurosurg Psychiatry 2001, 71:488-492.
30. Takahashi Y., Takata T., Hoshino M., Sakurai M., Kanazawa I. Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjogren's syndrome. IV immunoglobulin. Neurology 2003, 60:503-505.
31. Chen W.H., Yeh J.H., Chiu H.C. Plasmapheresis in the treatment of ataxic sensory neuropathy associated with Sjogren's syndrome. Eur Neurol 2001, 45:270-274.
32. Asahina M., Kuwabara S., Nakajima M., Hattori T. D-penicillamine treatment for chronic sensory ataxic neuropathy associated with Sjogren's syndrome. Neurology 1998, 51:1451-1453.
33. Caroyer J.M., Manto M.U., Steinfeld S.D. Severe sensory neuronopathy responsive to infliximab in primary Sjogren's syndrome. Neurology 2002, 59:1113-1114.
34. Yamada S., Mori K., Matsuo K., Inukai A., Kawagashira Y., Sobue G. Interferon alfa treatment for Sjogren's syndrome associated neuropathy. J Neurol Neurosurg Psychiatry 2005, 76:576-578.
35. Gorson K.C., Natarajan N., Ropper A.H., Weinstein R. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial. Muscle Nerve 2007, 35:66-69.
36. Kosmidis M.L., Dalakas M.C. Practical considerations on the use of rituximab in autoimmune neurological disorders. Ther Adv Neurol Disord 2010, 3:93-105.
37. Hoitsma E., Reulen J.P., de Baets M., Drent M., Spaans F., Faber C.G. Small fiber neuropathy: a common and important clinical disorder. J Neurol Sci 2004, 227:119-130.
38. Lacomis D. Small-fiber neuropathy. Muscle Nerve 2002, 26:173-188.
39. Goransson L.G., Brun J.G., Harboe E., Mellgren S.I., Omdal R. Intraepidermal nerve fiber densities in chronic inflammatory autoimmune diseases. Arch Neurol 2006, 63:1410-1413.
40. Omdal R., Mellgren S.I., Goransson L., Skjesol A., Lindal S., Koldingsnes W., et al. Small nerve fiber involvement in systemic lupus erythematosus: a controlled study. Arthritis Rheum 2002, 46:1228-1232.
41. Gondim F.A., Brannagan T.H., Sander H.W., Chin R.L., Latov N. Peripheral neuropathy in patients with inflammatory bowel disease. Brain: J Neurol 2005, 128:867-879.
42. Bakkers M., Merkies I.S., Lauria G., Devigili G., Penza P., Lombardi R., et al. Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology 2009, 73:1142-1148.
43. Hoitsma E., Marziniak M., Faber C.G., Reulen J.P.H., Sommer C., De Baets M., et al. Small fibre neuropathy in sarcoidosis. Lancet 2002, 359:2085-2086.
44. Chai J., Herrmann D.N., Stanton M., Barbano R.L., Logigian E.L. Painful small-fiber neuropathy in Sjogren syndrome. Neurology 2005, 65:925-927.
45. Mori K., Iijima M., Sugiura M., Koike H., Hattori N., Ito H., et al. Sjogren's syndrome associated painful sensory neuropathy without sensory ataxia. J Neurol Neurosurg Psychiatry 2003, 74:1320-1322.
46. Fauchais A.L., Richard L., Gondran G., Ghorab K., Palat S., Bezanahary H., et al. La Revue de medecine interne/fondee par la Societe nationale francaise de medecine interne 2011, 32:142-148.
47. Gorson K.C., Herrmann D.N., Thiagarajan R., Brannagan T.H., Chin R.L., Kinsella L.J., et al. Non-length dependent small fibre neuropathy/ganglionopathy. J Neurol Neurosurg Psychiatry 2008, 79:163-169.
48. England J.D., Gronseth G.S., Franklin G., Carter G.T., Kinsella L.J., Cohen J.A., et al. Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve 2009, 39:106-115.
49. Lauria G., Cornblath D.R., Johansson O., McArthur J.C., Mellgren S.I., Nolano M., et al. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol: Official J Eur Fed Neurol Soc 2005, 12:747-758.
50. Morozumi S., Kawagashira Y., Iijima M., Koike H., Hattori N., Katsuno M., et al. Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjogren's syndrome. J Neurol Sci 2009, 279:57-61.
51. Vlckova-Moravcova E., Bednarik J., Dusek L., Toyka K.V., Sommer C. Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies. Muscle Nerve 2008, 37:50-60.
52. Ioannidis J.P., Vassiliou V.A., Moutsopoulos H.M. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome. Arthritis Rheum 2002, 46:741-747.
53. Sene D., Jallouli M., Lefaucheur J.P., Saadoun D., Costedoat-Chalumeau N., Maisonobe T., et al. Peripheral neuropathies associated with primary Sjogren syndrome: immunologic profiles of nonataxic sensory neuropathy and sensorimotor neuropathy. Medicine 2011, 90:133-138.
54. Tzioufas A.G., Boumba D.S., Skopouli F.N., Moutsopoulos H.M. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjogren's syndrome. Arthritis Rheum 1996, 39:767-772.
55. Voulgarelis M., Giannouli S., Tzioufas A.G., Moutsopoulos H.M. Long term remission of Sjogren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone). Ann Rheum Dis 2006, 65:1033-1037.
56. Dalakas M.C. Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat Rev Neurol 2011.
57. Hughes R.A., Donofrio P., Bril V., Dalakas M.C., Deng C., Hanna K., et al. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol 2008, 7:136-144.
58. Collins M.P., Mendell J.R., Periquet M.I., Sahenk Z., Amato A.A., Gronseth G.S., et al. Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology 2000, 55:636-643.
59. Terrier B., Lacroix C., Guillevin L., Hatron P.Y., Dhote R., Maillot F., et al. Diagnostic and prognostic relevance of neuromuscular biopsy in primary Sjogren's syndrome-related neuropathy. Arthritis Rheum 2007, 57:1520-1529.
60. Schaublin G.A., Michet C.J., Dyck P.J., Burns T.M. An update on the classification and treatment of vasculitic neuropathy. Lancet Neurol 2005, 4:853-865.
61. Jayne D., Rasmussen N., Andrassy K., Bacon P., Tervaert J.W., Dadoniene J., et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003, 349:36-44.
62. Pagnoux C., Mahr A., Hamidou M.A., Boffa J.J., Ruivard M., Ducroix J.P., et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med 2008, 359:2790-2803.
63. Keogh K.A., Wylam M.E., Stone J.H., Specks U. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005, 52:262-268.
64. Barendregt P.J., Markusse H.M., Man In 't Veld A.J. Primary Sjogren's syndrome presenting as autonomic neuropathy. Case report. Neth J Med 1998, 53:196-200.
65. Sorajja P., Poirier M.K., Bundrick J.B., Matteson E.L. Autonomic failure and proximal skeletal myopathy in a patient with primary Sjogren syndrome. Mayo Clin Proc 1999, 74:695-697.
66. Andonopoulos A.P., Ballas C. Autonomic cardiovascular neuropathy in primary Sjogren's syndrome. Rheumatol Int 1995, 15:127-129.
67. Klein C.M., Vernino S., Lennon V.A., Sandroni P., Fealey R.D., Benrud-Larson L., et al. The spectrum of autoimmune autonomic neuropathies. Ann Neurol 2003, 53:752-758.
68. Vernino S., Low P.A., Fealey R.D., Stewart J.D., Farrugia G., Lennon V.A. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 2000, 343:847-855.
69. Andonopoulos A.P., Christodoulou J., Ballas C., Bounas A., Alexopoulos D. Autonomic cardiovascular neuropathy in Sjogren's syndrome. A controlled study. J Rheumatol 1998, 25:2385-2388.
70. Cai F.Z., Lester S., Lu T., Keen H., Boundy K., Proudman S.M., et al. Mild autonomic dysfunction in primary Sjogren's syndrome: a controlled study. Arthritis Res Ther 2008, 10:R31.
71. Mandl T., Granberg V., Apelqvist J., Wollmer P., Manthorpe R., Jacobsson L.T. Autonomic nervous symptoms in primary Sjogren's syndrome. Rheumatology (Oxford, England) 2008, 47:914-919.
72. Mandl T., Jacobsson L., Lilja B., Sundkvist G., Manthorpe R. Disturbances of autonomic nervous function in primary Sjogren's syndrome. Scand J Rheumatol 1997, 26:401-406.
73. Hammar O., Ohlsson B., Wollmer P., Mandl T. Impaired gastric emptying in primary Sjogren's syndrome. J Rheumatol 2010, 37:2313-2318.
74. Kovacs L., Papos M., Takacs R., Roka R., Csenke Z., Kovacs A., et al. Autonomic nervous system dysfunction involving the gastrointestinal and the urinary tracts in primary Sjogren's syndrome. Clin Exp Rheumatol 2003, 21:697-703.
75. Niemela R.K., Hakala M., Huikuri H.V., Airaksinen K.E. Comprehensive study of autonomic function in a population with primary Sjogren's syndrome. No evidence of autonomic involvement. J Rheumatol 2003, 30:74-79.
76. Niemela R.K., Pikkujamsa S.M., Hakala M., Huikuri H.V., Airaksinen K.E. No signs of autonomic nervous system dysfunction in primary Sjorgen's syndrome evaluated by 24 hour heart rate variability. J Rheumatol 2000, 27:2605-2610.
77. Mandl T., Wollmer P., Manthorpe R., Jacobsson L.T. Autonomic and orthostatic dysfunction in primary Sjogren's syndrome. J Rheumatol 2007, 34:1869-1874.
78. Mandl T., Hammar O., Theander E., Wollmer P., Ohlsson B. Autonomic nervous dysfunction development in patients with primary Sjogren's syndrome: a follow-up study. Rheumatology (Oxford, England) 2010, 49:1101-1106.
79. Gorson K.C. Vasculitic neuropathies: an update. Neurologist 2007, 13:12-19.
80. Alexander E.L. Neurologic disease in Sjogren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis. Rheum Dis Clin North Am 1993, 19:869-908.
81. Alexander E.L., Provost T.T., Stevens M.B., Alexander G.E. Neurologic complications of primary Sjogren's syndrome. Medicine (Baltimore) 1982, 61:247-257.
82. Ramos-Casals M., Anaya J.M., Garcia-Carrasco M., Rosas J., Bove A., Claver G., et al. Cutaneous vasculitis in primary Sjogren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore) 2004, 83:96-106.
83. Mellgren S.I., Conn D.L., Stevens J.C., Dyck P.J. Peripheral neuropathy in primary Sjogren's syndrome. Neurology 1989, 39:390-394.
84. Malinow K., Yannakakis G.D., Glusman S.M., Edlow D.W., Griffin J., Pestronk A., et al. Subacute sensory neuronopathy secondary to dorsal root ganglionitis in primary Sjogren's syndrome. Ann Neurol 1986, 20:535-537.
85. Uceyler N., Kafke W., Riediger N., He L., Necula G., Toyka K.V., et al. Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology 2010, 74:1806-1813.
86. Moll J.W., Markusse H.M., Pijnenburg J.J., Vecht C.J., Henzen-Logmans S.C. Antineuronal antibodies in patients with neurologic complications of primary Sjogren's syndrome. Neurology 1993, 43:2574-2581.
87. Murata Y., Maeda K., Kawai H., Terashima T., Okabe H., Kashiwagi A., et al. Antiganglion neuron antibodies correlate with neuropathy in Sjogren's syndrome. Neuroreport 2005, 16:677-681.
88. Satake M., Yoshimura T., Iwaki T., Yamada T., Kobayashi T. Anti-dorsal root ganglion neuron antibody in a case of dorsal root ganglionitis associated with Sjogren's syndrome. J Neurol Sci 1995, 132:122-125.
89. Bhanji R.A., Eystathioy T., Chan E.K., Bloch D.B., Fritzler M.J. Clinical and serological features of patients with autoantibodies to GW/P bodies. Clin Immunol (Orlando Fla) 2007, 125:247-256.
90. Eystathioy T., Chan E.K., Takeuchi K., Mahler M., Luft L.M., Zochodne D.W., et al. Clinical and serological associations of autoantibodies to GW bodies and a novel cytoplasmic autoantigen GW182. J Mol Med (Berlin, Germany) 2003, 81:811-818.
91. Haneji N., Nakamura T., Takio K., Yanagi K., Higashiyama H., Saito I., et al. Identification of α-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science 1997, 276:604-607.
92. de Seze J., Dubucquoi S., Fauchais A.L., Hachulla E., Matthias T., Lefranc D., et al. Autoantibodies against alpha-fodrin in Sjogren's syndrome with neurological manifestations. J Rheumatol 2004, 31:500-503.
93. Ruiz-Tiscar J.L., Lopez-Longo F.J., Sanchez-Ramon S., Santamaria B., Urrea R., Carreno L., et al. Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndrome. Ann N Y Acad Sci 2005, 1050:210-216.
94. Ruffatti A., Ostuni P., Grypiotis P., Botsios C., Tonello M., Grava C., et al. Sensitivity and specificity for primary Sjogren's syndrome of IgA and IgG anti-alpha-fodrin antibodies detected by ELISA. J Rheumatol 2004, 31:504-507.
95. Dawson L., Tobin A., Smith P., Gordon T. Antimuscarinic antibodies in Sjogren's syndrome: where are we, and where are we going?. Arthritis Rheum 2005, 52:2984-2995.
96. Bacman S., Perez Leiros C., Sterin-Borda L., Hubscher O., Arana R., Borda E. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjogren's syndrome. Invest Ophthalmol Vis Sci 1998, 39:151-156.
97. Bacman S., Sterin-Borda L., Camusso J.J., Arana R., Hubscher O., Borda E. Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjogren's syndrome. Clin Exp Immunol 1996, 104:454-459.
98. Gao J., Cha S., Jonsson R., Opalko J., Peck A.B. Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjogren's syndrome patients by use of a transfected cell line assay. Arthritis Rheum 2004, 50:2615-2621.
99. Marczinovits I., Kovacs L., Gyorgy A., Toth G.K., Dorgai L., Molnar J., et al. A peptide of human muscarinic acetylcholine receptor 3 is antigenic in primary Sjogren's syndrome. J Autoimm 2005, 24:47-54.
100. Naito Y., Matsumoto I., Wakamatsu E., Goto D., Sugiyama T., Matsumura R., et al. Muscarinic acetylcholine receptor autoantibodies in patients with Sjogren's syndrome. Ann Rheum Dis 2005, 64:510-511.
101. Dawson L.J., Allison H.E., Stanbury J., Fitzgerald D., Smith P.M. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches. Rheumatology (Oxford, England) 2004, 43:1488-1495.
102. Roescher N., Kingman A., Shirota Y., Chiorini J.A., Illei G.G. Peptide-based ELISAs are not sensitive and specific enough to detect muscarinic receptor type 3 autoantibodies in serum from patients with Sjogren's syndrome. Ann Rheum Dis 2011, 70:235-236.
103. Park K., Haberberger R.V., Gordon T.P., Jackson M.W. Antibodies interfering with the muscarinic 3 receptor pathway in Sjogren's syndrome inhibit gastrointestinal motility and cholinergic neurotransmission. Arthritis Rheum 2011.
104. Waterman S.A., Gordon T.P., Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome. Arthritis Rheum 2000, 43:1647-1654.
105. Dawson L.J., Stanbury J., Venn N., Hasdimir B., Rogers S.N., Smith P.M. Antimuscarinic antibodies in primary Sjogren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum 2006, 54:1165-1173.
106. Wang F., Jackson M.W., Maughan V., Cavill D., Smith A.J., Waterman S.A., et al. Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder. Arthritis Rheum 2004, 50:3637-3645.
107. McKeon A., Lennon V.A., Lachance D.H., Fealey R.D., Pittock S.J. Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments. Arch Neurol 2009, 66:735-741.